Why insider trading matters?

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

- Peter Lynch
Regulus Therapeutics Inc. (RGLS)
Sector: Healthcare; Industry: Biotechnology

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that target microRNAs to treat a range of diseases in the United States and Europe. Its two lead product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS4326, an anti-miR targeting miR-17, which is in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-26 Hagan Joseph P President and CEO Buy 100,000 $0.22 $21,520 Yes
2021-05-17 Aker Christopher Ray Sr. VP & General Counsel Sell 860 $0.89 $765 No
2021-02-16 Hagan Joseph P President and CEO Sell 4,144 $1.72 $7,128 No
2021-02-16 Aker Christopher Ray Sr. VP & General Counsel Sell 828 $1.72 $1,424 No
2021-02-16 Hagan Joseph P President and CEO Sell 4,144 $1.72 $7,128 No
2020-12-04 Walker Paul Edward 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Sonsini Peter W. 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 SANDELL SCOTT D 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 MAKOWER JOSHUA 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Makhzoumi Mohamad 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Florence Anthony A. Jr. 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Chang Carmen 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Behbahani Ali 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 BASKETT FOREST 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-12-04 Growth Equity Opportunities V, LLC 10%-Owner Buy 4,398,602 $0.62 $2,735,930 Yes
2020-11-16 Aker Christopher Ray Sr. VP & General Counsel Sell 876 $0.52 $456 No
2020-11-16 Hagan Joseph P President and CEO Sell 6,094 $0.52 $3,176 No
2020-08-14 Hagan Joseph P President and CEO Sell 4,245 $0.60 $2,568 No
2020-08-14 Aker Christopher Ray Sr. VP & General Counsel Sell 872 $0.60 $528 No
2020-05-15 Hagan Joseph P President and CEO Sell 4,426 $0.63 $2,774 No
2020-05-15 Aker Christopher Ray Sr. VP & General Counsel Sell 909 $0.63 $570 No
2020-02-18 Hagan Joseph P President and CEO Sell 4,324 $0.83 $3,591 No
2020-02-18 Aker Christopher Ray Sr. VP & General Counsel Sell 888 $0.83 $737 No
2020-01-02 Hagan Joseph P President and CEO Sell 8,345 $0.97 $8,067 No
2020-01-02 Aker Christopher Ray Sr. VP & General Counsel Sell 2,239 $0.97 $2,164 No
2019-11-14 Aker Christopher Ray Sr. VP & General Counsel Sell 833 $0.64 $533 No
2019-11-14 Hagan Joseph P President and CEO Sell 5,838 $0.64 $3,736 No
2019-10-01 Aker Christopher Ray Sr. VP & General Counsel Sell 2,346 $0.68 $1,602 No
2019-10-01 Hagan Joseph P President and CEO Sell 8,743 $0.68 $5,969 No
2019-08-15 Hagan Joseph P President and CEO Sell 4,375 $0.55 $2,409 No

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.

Insider Smart

CEDAR FAIR L.P. (FUN) - Another crash victim, Cedar Fair L.P. took a deep dive from $54 to $13, insiders were confidence and eagerly jumped in around $27. With insiders on your side, this would be an easy add and hold to get your cost under $20. Stock is about to breach $40 in the coming weeks.